Download presentation
Presentation is loading. Please wait.
Published byCora Johnston Modified over 8 years ago
1
Complement Male, Immunology, 2006 Zipfel, Nature, 2009 Mobeen Syed ب Dr. Yıldıran1
2
Objectives You should say: Basic functions How works Its place and importance in immune reactions Dr. Yıldıran2
3
Non-specific immunity (Innate) Specific immunity (Adaptive) Immune System Delayed reaction MEMORY! Fast reaction Dr. Yıldıran3
4
Immune Response Abbas, 2003 Dr. Yıldıran4
5
Serum vs Plasma If you wait blood in a glass tube, blood coagulated, serum separated It does not contain fibrinogen Dr. Yıldıran5
6
Complement System Many plasma proteins, nine are essential. 10% of plasma proteins as pro-enzymes It was named as ‘Complement’ in 19th century because of thinking about it completes bactericidal feature of serum. Dr. Yıldıran6
7
Complement Proteins C1, C2, C3, C4, C5, C6, C7, C8, C9 Underlined parts do not cleaved When cleaved; C2b (big part) and C2a (anaphylaxis part) C6, C7, C8, C9 are not enzymes C6, C7, C8 binded with C9 Main activating molecule is C3 Dr. Yıldıran7
8
Basic Function Recognizing and clearing the FOREIGN For this, Complement –Starts and increases inflammation –Increases chemotaxis and phagocytosis –Cleares immune complexes –Activates cells –Kills directly –Provides antibody response. Dr. Yıldıran8
9
Functions in Inflammation C3b Dr. Yıldıran9
10
Four Plasma Cascades Pain Plug DIC Inflam. Dr. Yıldıran10
11
Simple Mechanism IgG and IgM C1 C4 Innate arm Spontaneous activation Endotoxin C3 and B C3 Adaptive arm Antibody activation Dr. Yıldıran11
12
Dr. Yıldıran12 EDEMA
13
C1qrs Electron Microscobe Dr. Yıldıran13
14
Membran activating complex Elektron Mikroskobu ile Dr. Yıldıran14
15
Some Functions C5a → Chemotaxis, inflammation C3a and C5a (Anaphylotoxins) → Mast cell and basophil activation (Anaphylaxis), inflammation C3b → –Opsonisation, –Clearing immune complexes, –B cell activation –Clearing apopitotic cells –Asplenic patients can not grab C3b-bacteria complex –Increases plasma cell antibody secretion MAC → Lysis of Gr negative (Especially Neisseria) some viruses Dr. Yıldıran15
16
Clinical evaluation C3 (0.75-1.61 g/L) C4 (0.2-0.5 g/L) CH50 → Classical pathway AH50 → Alternative pathway Dr. Yıldıran16
17
Control of Complement System IF not Autoimmunity Dr. Yıldıran17
18
CD18CD11b,c PNH Dr. Yıldıran18
19
Regulation P (Properdin)stabilizes C3bBb and prevent inactivation by H,I D cleaves B to Bb Properdin and Factor D deficiencies are PID Factor H binds C3b Factor I destroys C3b-factor H complex C1 inh, regulates classical pathway inhibiting C1q and s Dr. Yıldıran19
20
In disease Atypical HUS (no diarrhea): heterozygot factor H mutation Dense deposite disease (MPGN II): homozygot or compound heterozygot C3 or factor B (C3 convertase stage), otoantikor oluşumu (C3 nephritic factor) Age-related macular degeneration: retinal Bruch membrane or glomerule basal membrane; factor H or C3 mutation Dr. Yıldıran20
21
Autoimmune diseases C1q and C4 deficiency: clearing of apopitotic cells impairs. Homozygot defects in C1q, C1r, C1s, C2, C3 or C4 genes: rheumatic diseases, especially SLE. C1qinh defect → Hereditary angioedema Dr. Yıldıran21
22
Tumors In some tumors, inhibitors of complement on cell membrane (CD46, CD55, CD59) changed. soluble regulators (factor H, factor I, C4BP) expression increased on lung, ovary, glial and bowel cancer cell membranes and plasma. Namely, tumor cells hide from CD8 cytotoxic cells. Dr. Yıldıran22
23
Eculizumab C5 monoclonal antibody Inhibits complement system on C5 convertase. Dr. Yıldıran23
24
Hereditary angioedema Dr. Yıldıran24
25
Neonatal Lupus Dermatology.cdlib.org Dr. Yıldıran25
26
Meningococcemia Dr. Yıldıran26
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.